During development and throughout life, a variety of specialized cells must be generated to ensure the proper function of each tissue and organ. Chromatin plays a key role in determining cellular state, whether totipotent, pluripotent, multipotent, or differentiated. We highlight chromatin dynamics involved in the generation of pluripotent stem cells as well as their influence on cell fate decision and reprogramming. We focus on the capacity of histone variants, chaperones, modifications, and heterochromatin factors to influence cell identity and its plasticity. Recent technological advances have provided tools to elucidate the underlying chromatin dynamics for a better understanding of normal development and pathological conditions, with avenues for potential therapeutic application.
T he genome of eukaryotic cells is organized into chromatin, a nuclear complex comprising DNA, RNA, and associated proteins (1, 2) . Chromatin organization displays hierarchical levels ranging from the basic repeated unit, the nucleosome, to higher-level structures (Fig. 1) . The nucleosome is composed of a core particle with~147 base pairs of doublestranded DNA wrapped around histone proteins with linker DNA joining core nucleosomal units. The chromatin filament further coils and compacts DNA to reach higher-order states with interacting chromatin loops and topologically associating domains (TADs) (3) . Histones come as distinct variants that undergo posttranslational modification (PTM) to provide modularity within core particles (1) . Histone chaperones, chromatin remodelers, and histone-and DNA-modifying enzymes, along with PTM readers, transcription factors, and RNA, generate specialized genomic domains for a versatile chromatin landscape. Centromeres, telomeres, and regulatory elements display unique nucleosome composition and structure. Modulation at each level enables chromatin-based information to vary in order to respond to different signals for numerous gene regulatory functions (4) (Fig. 1 ). This defines chromatin plasticity as a means to generate a diversity of properties for each cell type during development and also when cells face different environmental factors, genotoxic insults, metabolic changes, senescence, disease, and even death (5, 6) .
Regulation of cell fate decisions and cell identity can exploit chromatin, for example, by restricting access to a particular transcription factor or by providing distinct marks that specific proteins can recognize-proteins often called "reader"-and can interpret in response to signaling (7, 8) . Thus, chromatin organization is intimately linked to varied states experienced by any single cell in its lifetime, and many chromatin changes occur during embryonic development in mammals (6, 9) , in embryonic stem cells (ESCs) transitioning to a differentiated state in vitro (10) , during reprogramming of differentiated cells to form multi-or pluripotent cell types (11) , and in various diseases (12) . With the advent of single-cell approaches (13), we are beginning to capture transient or specialized states in individual cells. DNA methylation revealed major changes [see (4, 9, 14, 15) for reviews]. Here, we highlight recent reports that identify chromatin factors in controlling cell fate and identity with a focus on histone variants, PTMs, chaperones, and heterochromatin factors in the context of organism development, in vitro cell differentiation, cellular reprogramming, and disease.
Chromatin shapes cell fate and identity in normal development
During development, highly differentiated cells, the gametes, fuse to form a totipotent zygote. This single cell then undergoes rounds of division and differentiation to give rise to every cell type in the adult organism, including gametes. Lineage-specific gene expression profiles are initiated by cell type-specific transcription 1 of 5 factors and controlled by signal transduction pathways. Acting in concert, chromatin factors contribute to the chromatin landscape during stages of cellular differentiation and overall organism development. This is illustrated in particular with histone chaperones and their histone variants that perform critical roles in development (6) . Here, we compile recent reports placing them within the development cycle of an organism. We highlight the most drastic changes during gametogenesis and early zygotic development for reprogramming (Fig. 2) , with a focus on how heterochromatin can restrict cell fate.
Gametogenesis
In mammals, genome compaction in spermatogenesis involves major histone reshuffling. A spermatid-specific histone H2A variant, H2A. L.2, is required for the acquisition of nucleoprotamines and genome compaction in mature spermatozoa (16) (Fig. 2) . During compaction, it is necessary to mark chromatin at specific genes required for embryonic development. In zebrafish, specialized "placeholder" nucleosomes constitute a bookmarking mechanism to prevent DNA methylation-mediated repression at housekeeping and early embryonic transcription factor genes. They contain a special H2A variant, H2A.Z(FV), that co-occurs with the methylated histone H3 Lys 4 (H3K4me1) mark in transcriptionally silent gamete and embryonic stages of zebrafish development at key genomic regions in order to ensure a supply of housekeeping gene products and transcription factors (17) . Meanwhile, during oogenesis, certain histone PTMs differentiate active from inactive genomic regions. The trimethylated histone H3 Lys 4 (H3K4me3) mark generally correlates with active promoters but also occurs at a lesser degree at nonactive regions. Overcoming the limited amounts of mammalian genetic material available from eggs and embryos, two recent studies used low-input chromatin immunoprecipitation sequencing (ChIP-seq) to probe H3K4me3 levels during oogenesis (18, 19) . Whereas only active promoters in nondividing oocytes showed H3K4me3, this PTM accumulated further as oogenesis progressed in a transcription-independent manner involving the MLL2 activity (18) (ncH3K4me3; Fig. 2 ). This noncanonical transcription-independent H3K4me3 marked intergenic regions, putative enhancers, and trimethylated histone H3 Lys 27 (H3K27me3)-silent promoters. Moreover, the noncanonical H3K4me3 distributed over broad regions correlating with partially methylated DNA domains on maternal genomes in mature oocytes. The presence of these noncanonical H3K4me3 domains on the maternal allele in zygotes and two-cell embryos suggests inheritance from oocytes (19) , a feature distinct from somatic cells and ESCs. Thus, peculiar interplay between histone variants and key histone PTM shows remarkable dynamism as a marking system to prepare for subsequent development.
Zygotic development and cell trajectories
After fertilization, development starts based on maternally inherited proteins and RNAs from the egg cytoplasm. A crucial reprogramming of parental epigenomes occurs to reach zygotic totipotency. This transition involves the histone H3 variant H3.3 and its associated chaperones, HIRA and DAXX, important both for meiotic segregation and fertility in mammals (6) (Fig. 2) . After maternal-to-zygotic transition (MZT) and clearance of maternal products, zygotic genome activation (ZGA) is a time of extensive chromatin changes (14) . It takes place around the late twocell stage in mice and four-to eight-cell stages in human embryos. Recently, DNase I hypersensitivity (20) and scCOOL-seq (single-cell chromatin overall omics-scale landscape sequencing) experiments (21) showed a gradual reestablishment of chromatin accessibility in human embryos ( Fig. 2) . High-throughput ATAC-seq (assay for transposase-accessible chromatin) in human preimplantation embryos captured accessible chromatin regions existing prior to ZGA, especially at CpG-rich regions, several of them becoming inaccessible after ZGA in a transcriptiondependent manner (22) . Before gastrulation, spatial heterogeneity of regulatory genomic regions correlates with future cell fate. In flies, singlecell ATAC-seq studies at different developmental stages showed the dynamics of chromatin accessibility during lineage commitment (23) , demonstrating the temporal placement of cells along differentiation trajectories. During midand late embryonic stages, tissue-specific signatures of chromatin accessibility emerge, although individual cells still display features reminiscent of their original germ layer. The histone chaperone CAF-1 (specifically, the large subunit p150), which incorporates replicative histone variant H3.1 necessary for cell division, is crucial for preimplantation development (1, 2, 6) (Fig. 2) .
ZGA uses several barriers against precocious activation of lineage-specific genes in early embryogenesis. These include active and repressive histone PTMs. During ZGA in mice, reprogramming of the noncanonical histone mark H3K4me3 is observed. H3K4me3 inherited in preimplantation embryos gets removed by the lysine demethylases KDM5A and KDM5B (Fig. 2) to constrain this mark to transcription start sites (TSS) in the late two-cell embryos at the onset of zygotic transcription (24) . Thus, in contrast to oocytes with broad domains, H3K4me3 shows sharp, more confined peaks in late-stage embryos. Hence, a PTM associated with actively transcribed and poised gene promoters is highly plastic as embryos develop. Interestingly, the H3K27me3 mark associated with gene repression imposed by Polycomb complexes shows distinct dynamics. In Drosophila embryos, the maternal contribution of H3K27me3 counteracts premature untimely accumulation of the active H3K27ac mark at regulatory regions (25) . Indeed, loss of the maternally inherited H3K27me3 mark leads to embryonic lethality that cannot be circumvented by reestablishment , and heterochromatin factors are used during various stages of mouse development. The dynamic changes in the developmental cycle follow distinct steps: first an erasure or loss of parental marks during gametogenesis, followed by the mix of marks after fertilization to reach totipotency, and finally a progressive gain of specific chromatin marks and higher organization in line with the diversity of cell types forming the adult organism.
of the PTM at a later zygotic stage (25) . Similarly, a recent study in mice found that oocyteacquired H3K27me3 patterns are transmitted to the zygote and involved in a novel form of DNA methylation-independent genomic imprinting of allelic loci in early embryos (26) . Comparison of H3K4me3 and H3K27me3 dynamics by smallscale ChIP-seq revealed that whereas the active mark is rapidly reestablished, H3K27me3 is slower in preimplantation embryos in mouse, Xenopus, and zebrafish (27) .
Heterochromatin and cell fate restriction
Constitutive heterochromatin at pericentromeric regions is commonly associated with trimethylated histone H3 Lys 9 (H3K9me3) in cells (2, 28) , a mark that acts as a key chromatin barrier to cell fate changes. The genome-wide distribution in mouse gametes and early embryos (29) shows a dynamic distribution of H3K9me3 at promoters and long terminal repeats (LTRs). After fertilization, both parental genomes show massive H3K9me3 reprogramming and reestablishment, although the discrepancy in parental H3K9me3 signals lasts until the blastocyst stage and is not fully recovered. The large subunit of histone chaperone CAF-1 (mouse Chaf1a) is responsible for establishing H3K9me3 on LTRs and their eventual silencing (29, 30) . The observation of lineagespecific H3K9me3 raised interest in exploring roles for heterochromatin in regulating cell fate commitment. Loss of Setdb1 (H3K9 methyltransferase) in growing oocytes leads to meiotic defects and down-regulation of retrotransposon elements (31) , and Setdb1 maternally deficient embryos arrest at preimplantation as a result of cell cycle progression and chromosome segregation defects (Fig. 2) . The heterochromatin mark trimethylated histone 4 Lys 20 (H4K20me3) is undetectable in mouse preimplantation embryos, and ectopic establishment of this mark by expression of Suv4-20h1/h2 hinders development (Fig. 2) , likely by altering S-phase progression in this developmental context (32) . How these modifications interconnect with H3K27me3 will be important to consider.
As seen with H3K9me3 marks, after fertilization both parental genomes show remarkable loss of 3D nuclear structure in a low-input Hi-C study (33) . The higher-order states, as reflected with interacting chromatin loops and defined topologically associating domains (TADs), are thus lost. TAD boundaries and differential genomic compartments arise only gradually in the zygote, and a full restoration of the overall higher-order architecture involves a long maturation process (3) (Fig. 2) .
Together, these recent discoveries highlight critical chromatin dynamics during development and reproduction. Gametogenesis and developing embryos in model organisms teach us how the chromatin machinery contributes to fine-tuning of cell fate commitment. These mechanisms may also be reused during adult life in regenerating tissues and potentially exploited for therapeutic purposes in regenerative medicine.
Lessons from cellular models: Studying development in vitro
Cell culture of pluripotent ESCs (9) and 3D culture models have proven extremely useful for experimental manipulation of somatic and germline stem cells and organoids (34) . Recent findings show that ground-state (derived using the so-called "2i" combination of GSK3 and MEK inhibitors), serum-grown, or "primed" mouse ESCs (mESCs) and human ESCs exhibit features of accessible chromatin in comparison with somatic cells, although the features of chromatin are less distinct than in earlier preimplantation stages (35) . Recently, mESC lines with tagged H3.3 permitted the tracking of H3.3 dynamics before and after ESC differentiation (36, 37) . Notably, in ESCs, a hyperdynamic (-1 position) H3.3 nucleosome marks gene promoters; upon differentiation, this nucleosome shifts downstream (to the +1 position) (36) . These discrete dynamics in histone variant positioning suggest that fine-tuning at this level can regulate cell fate determination.
The lifetime of a particular histone variant is also a hallmark of stem cells, as shown in fly intestinal adult stem cells (ISCs). Notably, in ISCs, the specific centromeric variant CENP-A is retained for weeks in the self-renewing population-a mark of stemness (38) . A longlived form of CENP-A is thus characteristic of these populations of cells. In contrast, when these cells differentiate, in the daughter cells, the differentiating cell receives new CENP-A with the help of the fly version of the mammalian HJURP chaperone responsible for de novo CENP-A deposition, while the new daughter stem cell retains the parental CENP-A. This asymmetric distribution of the parental CENP-A follows the fate of the stem cell. These reports provide attractive cellular models to track cell fate changes and further probe the role of chromatin organization and dynamics of H3 variants.
Cellular models have also illuminated the importance of heterochromatin in the genome. HP1 (heterochromatin protein 1)/Suv39h1 (histone methyltransferase) recruitment to active promoters leads to reversible gene silencing in mESCs by establishing heterochromatin, as shown in experiments using FIRE-Cas9 (Fkbp/Frb inducible recruitment for epigenome editing by Cas9) (39) . Recent work in mESCs uncovered an unusual form of repression involving HP1 together with ADNP (activity-dependent neuroprotective protein) and CHD4 (chromatin remodeler) in a complex called ChAHP (40) . ChAHP-mediated repression acts locally and does not rely on H3K9me3-modified nucleosomes. Ablation of this complex led to spontaneous differentiation along with precocious expression of lineage-specific genes (40) . Bivalent promoters are defined by the presence of a nucleosome combining both an active mark (H3K4me3) and a repressive mark (H3K27me3) on the same particle and thus poised to either become activated or kept repressed. They are more prevalent in cultured mESCs than in mouse early embryos and provide an entry point to explore how their chromatin modulation contributes to transcriptional output. Activation of bivalent genes occurs within minutes at target loci in mESCs when targeting chromatin remodeling via mSWI/ SNF(BAF) complexes using the FIRECas9 method to oppose the activity of Polycomb complexes (39) . Conversely, the prevalence of Polycomb-mediated H3K27me3 at these promoters maintains them in a silent state. Intriguingly, H3K27 inheritance in mESCs may not be only self-sustained, as initially proposed, because these patterns can be established de novo (41) . This is in contrast to germline-inherited Polycomb memory in flies and mice, as discussed above (25, 26) . Hence, the maternally transmitted H3K27me3 that controls lineagespecific genes in vivo is not retained in the mESCs.
In common laboratory ESC cultures, most cells are pluripotent, with infrequent two-celllike cells exhibiting characteristics of totipotency with increased plasticity. Quantitative polymerase chain reaction-based microfluidics single-cell expression profiling characterized these two-celllike cells, and a small interfering RNA-based screening revealed key chromatin factors, including a noncanonical Polycomb PRC1 complex (PRC1.6) and the EP400-TIP60 complex (42) . Higher-order chromatin also undergoes dynamic changes during differentiation of stem cells, as shown by high-resolution ultradeep Hi-C mapping of the distinct signature in mESCs and neural progenitor cells where distal gene bodies of active genes interact extensively (43) . During neural differentiation, these preexisting longrange contacts between active TADs weaken while those between inactive regions become stronger. Cell type-specific enhancer-promoter contacts are formed in parallel to the expression of differentiation genes. Studies in ESCs have thus revealed unique roles of histone modifiers, variants, and chaperones in maintenance and/or changes in cellular identity that could also prove important for reprogramming.
Chromatin plasticity in cell reprogramming and deregulation in pathologies Manipulation in vitro affords the exciting possibility of reverting unipotent differentiated cells back to a pluripotent stem cell-like state, a process called reprogramming (11) , as in the case of induced pluripotent stem cells (iPSCs) derived directly from skin cells with a limited set of transcription factors (44) . However, the reprogramming efficiency remained limited, leading to a search for additional chromatin players involved in maintenance of somatic cell fate. The histone chaperone CAF-1, along with Setdb1, proved important in maintaining somatic cell identity (45) . Depletion of CAF-1 augments the reprogramming efficiency of mouse embryonic fibroblasts (MEFs) (45) . Interestingly, down-regulation of CAF-1(p150) in ESC leads to increased induction of 2C-like cells with greater potency than the ESC (30) . Notably, in addition to in vitro reprogramming, natural reprogramming also occurs in intestine regeneration and skin renewal of the adult organism. This is also exemplified by the immune response, which underscores the paradigm of chromatin plasticity in differentiated cells. Using single-cell RNA sequencing, a recent study found that CD8 + T cells lacking Suv39h1 have enhanced long-term memory and improved reprogramming capacity (46) . The stability of the commitment into T helper 2 (T H 2) lineage from CD4 + T cells is maintained by the SUV39H1-H3K9me3-HP1a pathway (46) . It is remarkable that in distinct contexts regarding the degree of cell potency, both CAF-1 and the H3K9me3-heterochromatin pathways (i.e., Setdb1, Suv39h1, HP1a) restrict acquisition of increased potency and/or remodeling capacity (Fig. 3) . Given the interactions and colocalization of CAF-1 with HP1 domains during S phase (47) (Fig. 4) , whether CAF-1 and H3K9me3-heterochromatin pathways act independently or in concert will need further investigation. Furthermore, how these chromatin modulations connect with the function of specific transcription factors and changes in the cell cycle remains to be established. Nonetheless, this provides an example of different, overlapping chromatin layers influencing cell fate decisions, which should be explored for regeneration of cells in the adult organism.
Deregulation during normal aging and in many disease states represent natural in vivo cases of unscheduled chromatin alterations and undesirable somatic cell fate changes. This is exemplified in aging and neurodegenerative diseases (48) . During advanced age-related macular degeneration (AMD), a major cause of vision loss in the elderly, chromatin accessibility (as determined by ATAC-seq) decreases globally in retinal pigmented epithelium (49) . Cancer, where pathological mechanisms likely hijack existing chromatin plasticity to cause disease, further underlines the role of chromatin. Consider p53-deficient tumors that show a dependence on high levels of HJURP, the CENP-A chaperone, thereby suggesting that centromeric chromatin integrity is involved in tumor maintenance (50) . HJURP is also an independent prognostic marker of luminal A breast carcinoma (51) . These data link together chromosomal architecture and centromere function in cell fate maintenance. In addition to the centromeric histone variant, other histone H3 variants (H3.1 and H3.3) and histone chaperones have been implicated in malignancies. Widespread efforts are under way to examine the molecular etiology of oncohistones carrying point mutations in histone H3 Lys 27 , Gly 34 , and Lys 36 linked to distinct cancer types, respectively (52, 53) . In these situations too, histone variant choice, histone chaperone, histone modifications, and heterochromatin are simultaneously involved in the dysregulation of cell identity.
A deeper understanding of the chromatin plasticity that wires these cell fate decisions is now guiding precision medicine and targeted therapeutics in a move toward cell precision medicine. Small-molecule inhibitors against EZH2 are being widely tested in trials along with other Polycomb subunit and BET bromodomain (chromatin reader domains that recognize acetylated histones) inhibitors that have shown therapeutic potential in diffuse intrinsic pontine glioma (DIPG) (53, 54) . Trying to better target the cells that are most susceptible to the intervention at the chromatin level will be crucial. Moving forward, the ability to obtain patient-derived iPSCs and organoids to carry out transdifferentiation offers new openings to examine and address aging as well as to treat diseases such as cancer and degenerative maladies.
Conclusion
Research in developmental and stem cell biology has become increasingly enmeshed with the study of chromatin-based regulatory mechanisms. Although cell identity and chromatin organization are intimately linked, understanding whether chromatin plasticity is the cause or consequence of cell fate changes requires further investigation with dedicated model systems. With the help of multidisciplinary approaches looking at single-cell dynamics with high-resolution imaging in combination with high-throughput "omics" methods, there is now hope to answer questions about cellular heterogeneity and cell identity specification with unprecedented precision (55, 56) . In regenerative medicine and disease treatment, targeting chromatin factors represents a promising avenue. Currently, immunotherapy and anticancer compounds combined with actionable chromatin targets are at the forefront of medicine. Multidisciplinary approaches will be instrumental to gain a comprehensive view of chromatin plasticity that may yield an understanding of how to switch between specific cellular states at will for therapeutic application.
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CAF-1(p150) DNA synthesis DAPI 5 µm Merge HP1α Fig. 4 . CAF-1 and heterochromatin marks within the cell. During late S phase at sites of 5-bromo-2′-deoxyuridine incorporation that reveal replication sites, CAF-1 closely localizes in foci with HP1a. A mouse embryonic fibroblast shows localization of the large subunit of CAF-1 (p150), HP1a, DNA synthesis, and DNA. We visualized p150 and HP1a by immunofluorescence staining, DNA synthesis by immunodetection of BrdU incorporation, and DNA by 4′,6-diamidino-2-phenylindole (DAPI) staining as described in (47) . A merge of the staining corresponding to detection of the large subunit of CAF-1 (p150) and HP1a is shown. The arrowheads point to (pericentric) heterochromatin domains.
